| Disease | prostate cancer |
| Symptom | C0004093|weakness |
| Sentences | 1 |
| PubMedID- 23089339 | Background: androgen deprivation therapy (adt) for prostate cancer (pca) is associated with weakness, fatigue, sarcopenia, and reduced quality of life (qol). |
Page: 1